170 related articles for article (PubMed ID: 35927674)
21. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
22. A Systematic Review and Meta-Analysis: Safety and Efficacy of Mesenchymal Stem Cells Therapy for Heart Failure.
Shen T; Xia L; Dong W; Wang J; Su F; Niu S; Wang Q; Fang Y
Curr Stem Cell Res Ther; 2021; 16(3):354-365. PubMed ID: 32867655
[TBL] [Abstract][Full Text] [Related]
23. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
[TBL] [Abstract][Full Text] [Related]
24. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
Heldman AW; DiFede DL; Fishman JE; Zambrano JP; Trachtenberg BH; Karantalis V; Mushtaq M; Williams AR; Suncion VY; McNiece IK; Ghersin E; Soto V; Lopera G; Miki R; Willens H; Hendel R; Mitrani R; Pattany P; Feigenbaum G; Oskouei B; Byrnes J; Lowery MH; Sierra J; Pujol MV; Delgado C; Gonzalez PJ; Rodriguez JE; Bagno LL; Rouy D; Altman P; Foo CW; da Silva J; Anderson E; Schwarz R; Mendizabal A; Hare JM
JAMA; 2014 Jan; 311(1):62-73. PubMed ID: 24247587
[TBL] [Abstract][Full Text] [Related]
25. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
Liau LL; Ruszymah BHI; Ng MH; Law JX
Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
[TBL] [Abstract][Full Text] [Related]
27. Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells.
Yamada Y; Minatoguchi S; Kanamori H; Mikami A; Okura H; Dezawa M; Minatoguchi S
J Cardiol; 2022 Jul; 80(1):80-87. PubMed ID: 34924234
[TBL] [Abstract][Full Text] [Related]
28. Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report.
López Y; Lutjemeier B; Seshareddy K; Trevino EM; Hageman KS; Musch TI; Borgarelli M; Weiss ML
Curr Stem Cell Res Ther; 2013 Jan; 8(1):46-59. PubMed ID: 23270633
[TBL] [Abstract][Full Text] [Related]
29. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Wang Z; Wang L; Su X; Pu J; Jiang M; He B
Stem Cell Res Ther; 2017 Jan; 8(1):21. PubMed ID: 28129790
[TBL] [Abstract][Full Text] [Related]
30. Major cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials.
Attar A; Hosseinpour A; Hosseinpour H; Kazemi A
BMC Cardiovasc Disord; 2022 Jun; 22(1):259. PubMed ID: 35681123
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
[TBL] [Abstract][Full Text] [Related]
32. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
Mathur A; Fernández-Avilés F; Bartunek J; Belmans A; Crea F; Dowlut S; Galiñanes M; Good MC; Hartikainen J; Hauskeller C; Janssens S; Kala P; Kastrup J; Martin J; Menasché P; Sanz-Ruiz R; Ylä-Herttuala S; Zeiher A;
Eur Heart J; 2020 Oct; 41(38):3702-3710. PubMed ID: 32860406
[TBL] [Abstract][Full Text] [Related]
33. Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.
Sürder D; Manka R; Lo Cicero V; Moccetti T; Rufibach K; Soncin S; Turchetto L; Radrizzani M; Astori G; Schwitter J; Erne P; Zuber M; Auf der Maur C; Jamshidi P; Gaemperli O; Windecker S; Moschovitis A; Wahl A; Bühler I; Wyss C; Kozerke S; Landmesser U; Lüscher TF; Corti R
Circulation; 2013 May; 127(19):1968-79. PubMed ID: 23596006
[TBL] [Abstract][Full Text] [Related]
34. [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction].
Yao K; Huang RC; Ge L; Qian JY; Li YL; Xu SK; Zhang F; Zhang YQ; Niu YH; Shi JH; Zhang SH; Fan B; Wang QB; Sun AJ; Zou YZ; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):577-81. PubMed ID: 17081355
[TBL] [Abstract][Full Text] [Related]
35. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
Borow KM; Yaroshinsky A; Greenberg B; Perin EC
Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
[TBL] [Abstract][Full Text] [Related]
36. Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity.
Bai J; Hu Y; Wang YR; Liu LF; Chen J; Su SP; Wang Y
J Geriatr Cardiol; 2012 Jun; 9(2):166-71. PubMed ID: 22916064
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction--MI3 Trial.
Nair V; Madan H; Sofat S; Ganguli P; Jacob MJ; Datta R; Bharadwaj P; Sarkar RS; Pandit AJ; Nityanand S; Goel PK; Garg N; Gambhir S; George PV; Chandy S; Mathews V; George OK; Talwar KK; Bahl A; Marwah N; Bhatacharya A; Bhargava B; Airan B; Mohanty S; Patel CD; Sharma A; Bhatnagar S; Mondal A; Jose J; Srivastava A;
Indian J Med Res; 2015 Aug; 142(2):165-74. PubMed ID: 26354213
[TBL] [Abstract][Full Text] [Related]
38. Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results.
Sürder D; Manka R; Moccetti T; Lo Cicero V; Emmert MY; Klersy C; Soncin S; Turchetto L; Radrizzani M; Zuber M; Windecker S; Moschovitis A; Bühler I; Kozerke S; Erne P; Lüscher TF; Corti R
Circ Res; 2016 Jul; 119(3):481-90. PubMed ID: 27267068
[TBL] [Abstract][Full Text] [Related]
39. Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem Cell Transplantation in Ischaemic Myocardium Study.
Moccetti T; Sürder D; Klersy C; Vassalli G; Crljenica C; Rossi MG; Pasotti E; Soldati G
Swiss Med Wkly; 2012; 142():w13632. PubMed ID: 22833405
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of magnetically labeled mesenchymal stem cells improves cardiac function in a swine myocardial infarction model.
Qi CM; Ma GS; Liu NF; Shen CX; Chen Z; Liu XJ; Hu YP; Zhang XL; Teng GJ; Ju SH; Ma M; Tang YL
Chin Med J (Engl); 2008 Mar; 121(6):544-50. PubMed ID: 18364144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
